The PAS is a standardized interview which assesses the changes seen in dementia and depression using a set of scales. There are three scales derived from an interview with the subject (cognitive impairment, depression, stroke) and three from an interview with an informant (cognitive decline, behavio
The cognitive decline scale of the psychogeriatric assessment scales (PAS): longitudinal data on its validity
✍ Scribed by A.F. Jorm; H. Christensen; P. A. Jacomb; A. E. Korten; A. J. Mackinnon
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 82 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.326
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Objective
The Cognitive Decline scale of the Psychogeriatric Assessment Scales (PAS)1 uses informant data to assess retrospectively change from earlier in life. Data from a 7–8‐year longitudinal study were used to assess the validity of this scale against changes in cognitive performance and mortality.
Copies of the PAS can be downloaded from the World Wide Web at http://www.mhri.edu.au/pas/
Design and measures
PAS data were collected on three occasions, with gaps of 3.6 and 4.1 years between the waves. The Cognitive Decline score at Wave 3 was validated retrospectively against actual change on a brief test of current cognitive status (the PAS Cognitive Impairment scale) over the three waves, while the Cognitive Decline score at Wave 1 was assessed for predictive validity against future mortality and cognitive change.
Setting
A community survey in the Australian cities of Canberra and Queanbeyan.
Participants
Participants were aged 70+ at the beginning of the study. The sample size varied from 729 to 279, depending on the number of waves involved.
Results
Participants with scores of 4+ on the Cognitive Decline scale at Wave 3 showed substantial deterioration over the previous 7–8 years. Scores of 4+ at Wave 1 predicted mortality and further cognitive deterioration.
Conclusions
The Cognitive Decline scale allows a valid retrospective assessment of change and has predictive validity for subsequent cognitive deterioration and increased mortality. Copyright © 2001 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract ## Objectives The cognitive subscale of the Alzheimer's Disease Assesment Scale (ADAS‐Cog) is the most widely used test in clinical trials dealing with Alzheimer's disease (AD). The aim of this study was to investigate the validity and reliability of the Turkish version of ADAS‐Cog. #